Local chemotherapy with cisplatin-depot for glioblastoma multiforme

Journal of Neuro-Oncology

Volumn 60, Issue 1, 2002, Pages 53-59

  Sheleg, Sergey V ^a   Korotkevich, Eugeny A ^b   Zhavrid, Edvard A ^a   Muravskaya, Galina V ^a   Smeyanovich, Arnold F ^a,b   Shanko, Yury G ^a,b   Yurkshtovich, Tatsiana L ^a,c   Bychkovsky, Pavel B ^c   Belyaev, Sergey A ^c  

^a Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^b Ministry of Health of the Republic of Belarus   (Belarus)

^c BELARUSIAN STATE UNIVERSITY   (Belarus)

Author keywords

Biodegradable polymer; Chemotherapy; Cisplatin; Glioblastoma multiforme

Indexed keywords

6 CARBOXYCELLULOSE POLYMER; CELLULOSE DERIVATIVE; CISPLATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BRAIN EDEMA; BRAIN RADIATION; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG EXPOSURE; DRUG IMPLANTATION; DRUG TOLERABILITY; FEMALE; GLIOBLASTOMA; HOMEOSTASIS; HUMAN; KAPLAN MEIER METHOD; MALE; NEUROPSYCHOLOGY; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; SEIZURE; STATISTICAL ANALYSIS; SURVIVAL TIME;

ABSORBABLE IMPLANTS; ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; SEIZURES;

EID: 0036795448     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020288015457     Document Type: Article

References (37)

1. Barker FG, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK, McDermott MW, Sneed PK, Wara WM, Wilson CB: Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 84: 1442-1448, 1996
2. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1-17, 1988
3. Barba D, Saris SC, Holder C, Rosenberg SA, Oldfield EH: Intratumoral LAK cell and interleukin-2 therapy of human gliomas. J Neurosurg 70: 175-182, 1989
4. Kubo O, Tajika Y, Muragaki Y, Nitta M, Kagawa M, Yoshida M, Kumakura M: Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites. Radiat Phys Chem 39, 521-525, 1992
5. Loeffler JS, Alexander E, Wen PY, Shea WM, Coleman CN, Kooy HM, Fine HA, Nedzi LA, Silver B, Riese NE: Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 82: 1918-1921, 1990
6. Tomita T: Interstitial chemotherapy for brain tumors: review. J Neuro-Oncol 10: 57-74, 1991
7. Willis BK, Heibrun MP, Sapozink MD, McDonald PR: Stereotactic interstitial brachytherapy of malignant astrocytomas with remarks on postimplantation computed tomographic appearance. Neurosurgery 23: 348-354, 1988
8. Brem H, Ewend MG, Piantadosi S, Greenhoot J, Burger PC, Sisti M: The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. J Neuro-Oncol 26: 111-123, 1995
9. Brem H, Mahaley MS Jr, Vick NA, Black KL, Schold SC Jr, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW: Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74: 441-446, 1991
10. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer Brain Tumor Treatment Group. Lancet 345: 1008-1012, 1995
11. Karnofsky DA: Meaningful clinical classification of therapeutic responses to anticancer drug. Clin Pharm Ther 2: 709-712, 1961
12. Goodman RS: Surgicel in the control of post-tonsillectomy bleeding. Laryngoscope 106: 1044-1046, 1996
13. Korotkevich EA, Smeyanovich AF, Sheleg SV, Zhavrid EA, Shanko YuG, Lukasheiko YuN, Muravskaya GV, Sinaiko VV, Bychkovsky PM, Yurkshtovich TL: Multimodal treatment of malignant cerebral glioma using cisplatin-depot as local chemotherapy. Zdravookhranenie 2: 11-14, 2000 (Russian)
14. Sheleg S, Zhavrid E, Korotkevich E, Smeyanovich A, Shanko Yu: Interstitial chemotherapy of newly diagnosed glioblastoma multiforme with cisplatin polymer implants. Ann Oncol 11: 13, 2000 (Abstract)
15. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
16. Sheleg SV, Nedzved MK: Morphologic changes in brain tissue after implantation of cisplatin-depot. Zdravookhranenie 6: 15-17, 2000 (Russian)
17. Drewinko B, Brown BW, Gottlieb JA: The effect of cis-diaminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications. Cancer Res 33: 3091-3095, 1973
18. Thomas DG, Darling JL, Paul EA, Mott TJ, Godlee JN, Tobias JS, Capra LG, Collins CD, Mooney C, Bozek T: Assay of anti-cancer drugs in tissue culture: relationship of relapse-free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. Br J Cancer 51: 525-532, 1985
19. Tofilon PJ, Williams ME, Barcellos MH, Deen DF: Comparison of the sister chromatid exchange and cell survival assays as a measure of tumor sensitivity in vitro to cis-diaminedichloroplatinum (II). Cancer Res 43: 3511-3513, 1983
20. Donelli MG, Zucchetti M, D'Incalci M: Do anticancer agents reach the tumor target in the human brain? Cancer Chemother Pharmacol 30: 251-260, 1992
21. Rall D, Zubrod C: Mechanisms of drug absorption and excretion: passage of drugs in and out of the central nervous system. Annu Rev Pharmacol Toxicol 2: 109-128, 1982
22. Thompson SW, Davis LE, Kornfeld M, Hilgers RD, Standefer JC: Cisplatin neuropathy, clinical, electrophysiology, morphologic, and toxicologic studies. Cancer 54: 1269-1275, 1984
23. Feun LG, Stewart DJ, Maor M, Leavens M, Savaraj N, Burgess MA, Yung WK, Benjamin RS: A pilot study of cis-diaminedichloroplatinum and radiation therapy in patients with high grade astrocytomas. J Neuro-Oncol 1: 109-113, 1983
24. Feun LG, Wallace S, Stewart DJ, Chuang VP, Yung WK, Leavens ME, Burgess MA, Savaraj N, Benjamin RS, Young SE: Intracarotid infusion of cis-diaminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 54: 794-799, 1984
25. Mahaley MS, Hipp SW, Dropcho EJ, Bertsch L, Cush S, Tirey T, Gillespie GY: Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 70: 371-378, 1989
26. Stewart DJ, O'Bryan RM, Al-Sarraf M, Costanzi JJ, Oishi N: Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group study. J Neuro-Oncol 1: 145-147, 1983
27. Bouvier G, Penn RD, Kroin JS, Béique RA, Guérard M-J, Lesage J: Stereotactic administration of intratumoral chronic chemotherapy of recurrent malignant gliomas. Appl Neurophysiol 50: 223-226, 1987
28. Begg AC, Bartelink H, Stewart FA, Brown DM, Luck EE: Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system. NCI Monogr 6: 133-136, 1988
29. Deurloo MJ, Kop W, van Tellingen O, Bartelink H, Begg AC: Intratumoral administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoral distribution. Cancer Chemother Pharmacol 27: 347-353, 1991
30. Hecquet B, Chabot F, Delatorre Gonzalez JC, Fournier C, Hilali S, Cambier L, Depadt G, Vert M: In vivo sustained release of cisplatin from bioresorbable implants in mice. Anticancer Res 6: 1251-12551, 1986
31. Nagase M, Nomura T, Nakajima T: Effects of intralesional versus ip administration of cisplatin on squamous cell carcinoma of mice. Cancer Treat Rep 71: 825-829, 1987
32. Kong Q, Kleinschmidt-Demasters BK, Lillehei KO: Intralesionally implanted cisplatin cures primary brain tumor in rats. J Surg Oncol 64: 268-273, 1997
33. Kong Q, Lillehei KO, Withrow SJ, DeMasters BK: The effect of local ATP administration as adjuvant therapy for 9L gliosarcoma in rats treated with interstitial sustained release cisplatin. Proc Am Assoc Cancer Res 35: 331, 1994 (Abstract)
34. Lillehei KO, Kong Q, Withrow SJ, Klenschmidt-DeMasters B: Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat. Neurosurgery 39: 1191-1197, 1996
35. Lillehei KO, Kong Q, Withrow SJ, DeMasters BK: Cisplatin administrated via sustained release biodegradable polymer appears superior to conventionally administered chemotherapy in the treatment of 9L gliosarcoma in rats. Proc Am Assoc Cancer Res 35: 417, 1994 (Abstract)
36. Burris H, Vogel C, Schwarz M: A phase I/II multicenter clinical trial of the cisplatin therapeutic implant (MPI 5010) for treatment of solid tumors. Proc 30th Annu Meet Am Soc Clin Oncol 13: 402, 1994 (Abstract)
37. Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diaminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474-2479, 1982